Monday, March 23, 2020

Global Clinical Trial Management Systems Industry - Major Growth Boosting Factors

According to latest research report "Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022", The global clinical trial management system (CTMS) market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. 

Factors such as significant outsourcing of clinical trial research to CROs, rising number of clinical trials, availability of advanced CTMS solutions, and rising government funds & grants to support clinical trials are driving the overall demand for CTMS across key markets.

Critical questions the report answers:

# What are the growth opportunities related to CTMS market across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of enterprise CTMS products. Will this scenario continue in the next five years?
# What are the various types of CTMS products and their market share in the overall market?
# What are the new trends and advancements in the clinical trials industry?

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@ 

Recent Developments

# In November 2017, Bio-Optronics and Complion entered into a partnership in order to integrate and develop their solutions, namely, CTMS and eRegulatory Solutions

# In September 2017, Pamplona completed the acquisition of Paraxel and bought its shares in order to help PARAXEL increase its productivity.

# In May 2017, Oracle opened its Oracle Cloud EU Region in Germany, with the addition of modern infrastructure as a service (IaaS) architecture and new IaaS and platform as a service (PaaS) cloud services.

# In January 2017, MedNet Solutions released the latest version of iMedNet with enhanced features

# In June 2016, Bio-Optronics launched the latest version of the Clinical Conductor CTMS.

By end user, the contract research organizations segment is expected to grow at the highest rate during the forecast period

By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies’ segment is sub-segmented into large pharmaceutical companies and mid-small pharmaceutical companies. The contract research organizations segment is expected to grow at the fastest rate during the forecast period in 2017. This is attributed to the rise in outsourcing of clinical trials by pharma and biotechnology companies to CROs.

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global clinical trial management system (CTMS) market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@ 

Geographical Growth Scenario:

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

Leading Market Players:

# Oracle (US)
# Medidata Solutions (US)
# PAREXEL (US)
# Bioclinica (US)
# Bio-Optronics (US)
# IBM (US) and many more…

No comments:

Post a Comment